NCT06963255

Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

Résultats Des Allogreffes artérielles conservée à +2/+8°C Dans Les REvascularisations en MIlieu Septique

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: Hospices Civils de Lyon · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included. Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modification of patient management is planned.

Conditions

• Revascularization in a Septic or Potentially Septic Environment

Interventions

Type	Name	Description
PROCEDURE	arterial revascularization	arterial revascularization

Timeline

• Start date: 2024-06-03
• Primary completion: 2025-12-01
• Completion: 2028-01-01
• First posted: 2025-05-08
• Last updated: 2025-05-08

Locations

2 sites across 1 country: France